These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26190441)

  • 1. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia.
    Parakh S; Wong HL; Rai R; Ali S; Field K; Shapiro J; Wong R; Nott L; Gibbs P; Yip D
    J Geriatr Oncol; 2015 Sep; 6(5):387-94. PubMed ID: 26190441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital.
    Gouverneur A; Rouyer M; Grelaud A; Robinson P; Colombani F; Terrebonne E; Smith D; Fourrier-Réglat A; Noize P
    Fundam Clin Pharmacol; 2017 Feb; 31(1):104-109. PubMed ID: 27600062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort study.
    Hurwitz HI; Bekaii-Saab TS; Bendell JC; Cohn AL; Kozloff M; Roach N; Mun Y; Fish S; Flick ED; Grothey A;
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):323-32. PubMed ID: 24686090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
    Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
    J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
    Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
    Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
    Kozloff M; Yood MU; Berlin J; Flynn PJ; Kabbinavar FF; Purdie DM; Ashby MA; Dong W; Sugrue MM; Grothey A;
    Oncologist; 2009 Sep; 14(9):862-70. PubMed ID: 19726453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.
    Wong HL; Lee B; Field K; Lomax A; Tacey M; Shapiro J; McKendrick J; Zimet A; Yip D; Nott L; Jennens R; Richardson G; Tie J; Kosmider S; Parente P; Lim L; Cooray P; Tran B; Desai J; Wong R; Gibbs P
    Clin Colorectal Cancer; 2016 Jun; 15(2):e9-e15. PubMed ID: 26968236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice.
    Field K; Shapiro J; Wong HL; Tacey M; Nott L; Tran B; Turner N; Ananda S; Richardson G; Jennens R; Wong R; Power J; Burge M; Gibbs P
    Intern Med J; 2015 Mar; 45(3):267-74. PubMed ID: 25403925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
    Bennouna J; Sastre J; Arnold D; Österlund P; Greil R; Van Cutsem E; von Moos R; Viéitez JM; Bouché O; Borg C; Steffens CC; Alonso-Orduña V; Schlichting C; Reyes-Rivera I; Bendahmane B; André T; Kubicka S;
    Lancet Oncol; 2013 Jan; 14(1):29-37. PubMed ID: 23168366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab treatment in the elderly patient with metastatic colorectal cancer.
    Di Bartolomeo M; Maggi C; Ricchini F; Pietrantonio F; Iacovelli R; de Braud F; Inno A
    Clin Interv Aging; 2015; 10():127-33. PubMed ID: 25584021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer.
    Loupakis F; Cremolini C; Salvatore L; Masi G; Sensi E; Schirripa M; Michelucci A; Pfanner E; Brunetti I; Lupi C; Antoniotti C; Bergamo F; Lonardi S; Zagonel V; Simi P; Fontanini G; Falcone A
    Eur J Cancer; 2014 Jan; 50(1):57-63. PubMed ID: 24138831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia.
    Hocking C; Broadbridge VT; Karapetis C; Beeke C; Padbury R; Maddern GJ; Roder DM; Price TJ
    Med J Aust; 2014 Oct; 201(8):462-6. PubMed ID: 25332033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience.
    Ocvirk J; Moltara ME; Mesti T; Boc M; Rebersek M; Volk N; Benedik J; Hlebanja Z
    Radiol Oncol; 2016 Jun; 50(2):226-31. PubMed ID: 27247556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients with colorectal cancer: treatment modalities and survival in France. National data from the ThInDiT cohort study.
    Doat S; Thiébaut A; Samson S; Ricordeau P; Guillemot D; Mitry E
    Eur J Cancer; 2014 May; 50(7):1276-83. PubMed ID: 24447833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer.
    Vrdoljak E; Omrčen T; Boban M; Hrabar A
    Anticancer Drugs; 2011 Feb; 22(2):191-7. PubMed ID: 21057306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
    Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
    Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease.
    Varol U; Cirak Y; Cakar B; Karaca B; Sezgin C; Uslu R; Karabulut B
    J BUON; 2013; 18(3):647-52. PubMed ID: 24065478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of bevacizumab on combination with chemotherapy in different lines of treatment for metastatic colorectal carcinoma.
    Kiss I; Bortlicek Z; Melichar B; Poprach A; Halamkova J; Vyzula R; Dusek L; Buchler T
    Anticancer Res; 2014 Feb; 34(2):949-54. PubMed ID: 24511038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.